Context and Aim: Mesenchymal stem cells (MSCs) and platelet-rich fibrin (PRF) have emerged as ideal candidates for advanced therapies of various therapeutically-challenging diseases; however, their regenerative potential in diabetic foot ulcers (DFU) has not been well determined. In this study, we reviewed our clinical experience in mitigating chronic ulcer complications of diabetic foot through a conventional treatment of autologous adipose-derived MSCs embedded in PRF with pure PRF injections. Materials and Methods: The present study was carried out in 10 patients with an open DFU wound selected over a period of 1 year starting from April 2019. Patients were either injected with PRF alone (Group A) or injected with MSCs derived from adipose tissue (ADMSC) embedded in (PRF (Group B). Results: Patients in Group B had a better healing index when compared to Group A. Conclusion: Use of ADMSC embedded in PRF showed promising results to treat DFU.
References
[1]
Lipsky, B.A., Berendt, A.R., Cornia, P.B., Pile, J.C., Peters, E.J.G., Armstrong, D.G., et al. (2012) Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections. Clinical Infectious Diseases, 54, e132-e173. https://doi.org/10.1093/cid/cis346
[2]
Çamur, S., Batlbay, S.G. and Bayram, S. (2020) Effect of Lower Extremity Amputation on Caregiving Burden in Caregivers of Patients with Diabetic Foot: Prospective Cohort Study. International Wound Journal, 17, 890-896. https://doi.org/10.1111/iwj.13342
[3]
Hicks, C.W., Selvarajah, S., Mathioudakis, N., Sherman, R.L., Hines, K.F., Black, J.H., et al. (2016) Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs. Annals of Vascular Surgery, 33, 149-158. https://doi.org/10.1016/j.avsg.2015.11.025
[4]
Obeid, M., Moughames, E., Aboulhosn, P., Madi, R., Farah, M., Feghali, J., et al. (2018) Epidemiology and Susceptibility Profiles of Diabetic Foot Infections in Five Hospitals in Lebanon. The Journal of Infection in Developing Countries, 12, 347-351. https://doi.org/10.3855/jidc.10063
[5]
Ubbink, D.T., Vermeulen, H. and Lubbers, M.J. (2006) Local Wound Care: Evidence-Based Treatments and Dressings. Nederlands Tijdschrift voor Geneeskunde, 150, 1165-1172.
[6]
Haleem, A.M., Singergy, A.E., Sabry, D., Atta, H.M., Rashed, L.A., Chu, C.R., et al. (2010) The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results. Cartilage, 1, 253-261. https://doi.org/10.1177/1947603510366027
[7]
Srinivas, B., Das, P., Rana, M.M., Qureshi, A.Q., Vaidya, K.C. and Ahmed Raziuddin, S.J. (2018) Wound Healing and Bone Regeneration in Postextraction Sockets with and without Platelet-Rich Fibrin. Annals of Maxillofacial Surgery, 8, 28-34. https://doi.org/10.4103/ams.ams_153_17
[8]
Zhao, J.-H., Tsai, C.-H. and Chang, Y.-C. (2011) Clinical and Histologic Evaluations of Healing in an Extraction Socket Filled with Platelet-Rich Fibrin. Journal of Dental Sciences, 6, 116-122. https://doi.org/10.1016/j.jds.2011.03.004
Gonzalez, A.C.O., Costa, T.F., Andrade, Z.A. and Medrado, A.R.A.P. (2016) Wound Healing—A Literature Review. Anais Brasileiros de Dermatologia, 91, 614-620. https://doi.org/10.1590/abd1806-4841.20164741
[11]
Full Article: Role of Growth Factors and Biomaterials in Wound Healing.
[12]
Follo, F., et al. (2017) Management and Effect of Platelet-Rich Plasma on Wound Healing: Small Reality of Oglio Po Hospital. Acta Bio Medica, 88, 66-70.
[13]
Gao, F., Chiu, S.M., Motan, A.L., Zhang, Z., Chen, L., Ji, H.-L., et al. (2016) Mesenchymal Stem Cells and Immunomodulation: Current Status and Future Prospects. Cell Death & Disease, 7, e2062. http://www.nature.com/articles/cddis2015327 https://doi.org/10.1038/cddis.2015.327
[14]
Amati, E., Sella, S., Perbellini, O., Alghisi, A., Bernardi, M., Chieregato, K., et al. (2017) Generation of Mesenchymal Stromal Cells from Cord Blood: Evaluation of in Vitro Quality Parameters Prior to Clinical Use. Stem Cell Research & Therapy, 8, 14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260040 https://doi.org/10.1186/s13287-016-0465-2
[15]
Grigore, T.V. and Cozma, C. (2018) Platelet-Rich Plasma as a Site-Targeted Approach in Wound Healing: A Molecular Perspective. Discoveries (Craiova), 6, e87. https://doi.org/10.15190/d.2018.8
[16]
Wang, X., Zhang, Y., Choukroun, J., Ghanaati, S. and Miron, R.J. (2018) Effects of an Injectable Platelet-Rich Fibrin on Osteoblast Behavior and Bone Tissue Formation in Comparison to Platelet-Rich Plasma. Platelets, 29, 48-55. https://doi.org/10.1080/09537104.2017.1293807
[17]
Leach, J.K. and Whitehead, J. (2017) Materials-Directed Differentiation of Mesenchymal Stem Cells for Tissue Engineering and Regeneration. ACS Biomaterials Science & Engineering, 4, 1115-1127.
[18]
Fuertes, M., Velasco, V., Larrañaga, G.-E. and Peirona, G. (2009) Our Experience in the Treatment of Chronic Ulcers Using Vivostat® PRF®. Series of 10 Cases. Cirugía Plástica Ibero-Latinoamericana, 35, 9.
[19]
Basic Principles of Wound Management—UpToDate. https://www.uptodate.com/contents/basic-principles-of-wound-management
[20]
Etulain, J. (2018) Platelets in Wound Healing and Regenerative Medicine. Platelets, 29, 556-568. https://doi.org/10.1080/09537104.2018.1430357
[21]
Mizukami, H. and Yagihashi, S. (2014) Exploring a New Therapy for Diabetic Polyneuropathy—The Application of Stem Cell Transplantation. Frontiers in Endocrinology, 5, 45. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988365 https://doi.org/10.3389/fendo.2014.00045
[22]
Evaluation of the Effect of Vivostat Platelet Rich Fibrin (PRF) in the Treatment of Diabetic Foot Ulcers—Full Text View—ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00770939
[23]
Hu, M.S., Borrelli, M.R., Lorenz, H., Longaker, M.T. and Wan, D.C. (2018) Mesenchymal Stromal Cells and Cutaneous Wound Healing: A Comprehensive Review of the Background, Role, and Therapeutic Potential. Stem Cells International, 2018, Article ID: 6901983. https://www.hindawi.com/journals/sci/2018/6901983 https://doi.org/10.1155/2018/6901983
[24]
Leitner, G.C., Gruber, R., Neumüller, J., Wagner, A., Kloimstein, P., Höcker, P., et al. (2006) Platelet Content and Growth Factor Release in Platelet-Rich Plasma: A Comparison of Four Different Systems. Vox Sanguinis, 91, 135-139. https://doi.org/10.1111/j.1423-0410.2006.00815.x
[25]
Zimmermann, R., Jakubietz, R., Jakubietz, M., Strasser, E., Schlegel, A., Wiltfang, J., et al. (2001) Different Preparation Methods to Obtain Platelet Components as a Source of Growth Factors for Local Application. Transfusion, 41, 1217-1224. https://doi.org/10.1046/j.1537-2995.2001.41101217.x
[26]
Eppley, B.L., Woodell, J.E. and Higgins, J. (2004) Platelet Quantification and Growth Factor Analysis from Platelet-Rich Plasma: Implications for Wound Healing. Plastic and Reconstructive Surgery, 114, 1502-1508. https://doi.org/10.1097/01.PRS.0000138251.07040.51
[27]
Du, H.-C., et al. (2017) Growth Factor-Reinforced ECM Fabricated from Chemically Hypoxic MSC Sheet with Improved in Vivo Wound Repair Activity. BioMed Research International, 2017, Article ID: 2578017. https://www.hindawi.com/journals/bmri/2017/2578017
[28]
Ono, I., Yamashita, T., Hida, T., Jin, H.-Y., Ito, Y., Hamada, H., et al. (2004) Combined Administration of Basic Fibroblast Growth Factor Protein and the Hepatocyte Growth Factor Gene Enhances the Regeneration of Dermis in Acute Incisional Wounds. Wound Repair and Regeneration, 12, 67-79. https://doi.org/10.1111/j.1067-1927.2004.012113.x-1
[29]
Rolfe, K.J. and Grobbelaar, A.O. (2012) A Review of Fetal Scarless Healing. International Scholarly Research Notices, 2012, Article ID: 698034. https://www.hindawi.com/journals/isrn/2012/698034 https://doi.org/10.5402/2012/698034
[30]
Caplan, A.I. (2019) Medicinal Signalling Cells: They Work, So Use Them. Nature, 566, 39. https://doi.org/10.1038/d41586-019-00490-6
